Thrive Capital

Thrive Capital is a private equity and venture capital firm that invests in technology and software companies.

CCI Score

-35.47

0.02% June 2

Latest Event

Thrive Capital Invests in Neuralink Funding Round

Thrive Capital participated as one of the investors in Neuralink's $650 million funding round, as reported by CNBC. The investment is directed toward advancing Neuralink's brain-computer interface technology, which is primarily aimed at restoring function for patients with severe paralysis.

Take Action

So what can you do? It's time to make tough choices. Where will you cast your vote?

Shop Alternatives SEE ALL: CoinFund

MK Capital

TCV
Use Your Voice OTHER TOOLS
Investigate
Share the Score SUPPORT CCI

TOADIE

Thrive Capital is currently rated as a Toadie.

-30 to -44 CCI Score

Companies scoring in this range actively seek to please authoritarian regimes. They offer proactive support and assistance in exchange for preferential treatment, compromising ethical standards for business gains and political favor.

Latest Events

JUN

02

2025

Thrive Capital Invests in Neuralink Funding Round
0.00

Thrive Capital participated as one of the investors in Neuralink's $650 million funding round, as reported by CNBC. The investment is directed toward advancing Neuralink's brain-computer interface technology, which is primarily aimed at restoring function for patients with severe paralysis.
MAR

21

2024

Thrive Capital Fails to Address Human Rights Due Diligence for Generative AI Investments
-35.47

On 21 March 2024, Thrive Capital did not respond to inquiries regarding its human rights due diligence procedures for its generative AI investments, raising concerns about its commitment to human rights and the potential societal impact of its investment strategies.
-40

Business Practices and Ethical Responsibility

March 19

Thrive Capital's failure to respond to questions about its human rights due diligence in the context of generative AI investments demonstrates a lack of accountability in its business practices and ethical responsibilities. This omission fuels concerns that the firm's investment decisions may be complicit in undermining human rights protections, particularly when investing in technologies with potential societal risks.

Thrive Capital did not reply to questions regarding human rights due diligence procedures for generative AI investments